Red blood cells from pluripotent stem cells for use in transfusion

Papers of special note have been highlighted as: ▪▪ of considerable interest

Bibliography

• 1  Leacock JH: On transfusion of blood in extreme cases of haemorrhage. Med. Chir. J. Rev.3,279–284 (1817).
  Google Scholar
• 2  Blundell J: An account of obstinate vomiting in which an attempt was made to prolong life by the injection of blood into veins. Med. Chir. Trans.10(Pt 2),296–311 (1819).
  Medline CASGoogle Scholar
• 3  Schmidt PJ, Leacock AG: Forgotten transfusion history: John Leacock of Barbados. BMJ325,1485–1487 (2002).
  Medline CASGoogle Scholar
• 4  Landsteiner K: Uber agglutinationserscheinungen normalen menschlichen blutes. Wien Klin. Wochenschr.14,1132–1134 (1901).
  Google Scholar
• 5  Loutit JF, Mollisson PL: Advantages of a disodium–citrate–glucose mixture as a blood preservative. BMJ2,744–745 (1943).
  Medline CASGoogle Scholar
• 6  Rous P, Turner JR: The preservation of living red blood cells in vitro. J. Exp. Med.23,219–248 (1916).
  Medline CASGoogle Scholar
• 7  Barbara J, Regan F, Contreras M: Transfusion Microbiology. Cambridge University Press, Cambridge, UK (2008).
  Google Scholar
• 8  National Blood Data Resource Center: Comprehensive Report on Blood Collection and Transfusion in the United States in 2001. AABB Press, Bethseda, MD, USA (2001).
  Google Scholar
• 9  Poel CVD, Janssen M: The collection, testing and use of blood and blood products in Europe in 2003. In: European Health Committee (CDSP) 56th Meeting. Strasbourg, France (2004).
  Google Scholar
• 10  Prinoth O: Systems for monitoring transfusion risk. Blood Transfus.6,86–92 (2008).
  MedlineGoogle Scholar
• 11  Basran S, Frumento RJ, Cohen A et al.: The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth. Analg.103,15–20 (2006).
  MedlineGoogle Scholar
• 12  Dzik W: Fresh blood for everyone? Balancing availability and quality of stored RBCs. Transfus. Med.18,260–265 (2008).
  Medline CASGoogle Scholar
• 13  Koch CG, Li L, Sessler DI et al.: Duration of red-cell storage and complications after cardiac surgery. N. Engl. J. Med.358,1229–1239 (2008).
  Medline CASGoogle Scholar
• 14  Tinmouth A, Fergusson D, Yee IC, Hebert PC: Clinical consequences of red cell storage in the critically ill. Transfusion46,2014–2027 (2006).
  MedlineGoogle Scholar
• 15  Zallen G, Offner PJ, Moore EE et al.: Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am. J. Surg.178,570–572 (1999).
  Medline CASGoogle Scholar
• 16  Berezina TL, Zaets SB, Morgan C et al.:Influence of storage on red blood cell rheological properties. J. Surg. Res.102,6–12 (2002).
  Medline CASGoogle Scholar
• 17  Card RT: Red cell membrane changes during storage. Transfus. Med. Rev.2,40–47 (1988).
  Medline CASGoogle Scholar
• 18  Wolfe LC: The membrane and the lesions of storage in preserved red cells. Transfusion25,185–203 (1985).
  Medline CASGoogle Scholar
• 19  Gilson CR, Kraus TS, Hod EA et al.: A novel mouse model of red blood cell storage and posttransfusion in vivo survival. Transfusion49(8),1546–1553 (2009).
  Medline CASGoogle Scholar
• 20  Spahn DR, Waschke KF, Standl T et al.: Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood-loss non-cardiac surgery: results of a European Phase 3 study. Anesthesiology97,1338–1349 (2002).
  MedlineGoogle Scholar
• 21  Tremper KK: Perfluorochemical “red blood cell substitutes”: the continued search for an indication. Anesthesiology97,1333–1334 (2002).
  MedlineGoogle Scholar
• 22  Creteur J, Sibbald W, Vincent JL: Hemoglobin solutions 0 not just red blood cell substitutes. Crit. Care Med.28,3025–3034 (2000).
  Medline CASGoogle Scholar
• 23  Stowell CP, Levin J, Spiess BD, Winslow RM: Progress in the development of RBC substitutes. Transfusion41,287–299 (2001).
  Medline CASGoogle Scholar
• 24  Winslow RM: Current status of blood substitute research: towards a new paradigm. J. Intern. Med.253,508–517 (2003).
  Medline CASGoogle Scholar
• 25  Spivak JL, Gascon P, Ludwig H: Anemia management in oncology and hematology. Oncologist14(Suppl. 1),43–56 (2009).
  Medline CASGoogle Scholar
• 26  Bonig H, Chang KH, Geisen C, Seifried E, Ware C: Blood types of current embryonic stem cell lines are not conducive to culturing “universal-donor” red blood cells. Transfusion48,1039–1040 (2008).
  MedlineGoogle Scholar
• 27  Douay L, Andreu G: Ex vivo production of human red blood cells from hematopoietic stem cells: what is the future in transfusion? Transfus. Med. Rev.21,91–100 (2007).
  MedlineGoogle Scholar
• 28  Douay L, Lapillonne H, Turhan AG: Stem cells – a source of adult red blood cells for transfusion purposes: present and future. Crit. Care Clin.25,383–398 (2009).
  Medline CASGoogle Scholar
• 29  Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID: Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat. Med.16,232–236 (2010).
  Medline CASGoogle Scholar
• 30  Jiang Y, Jahagirdar BN, Reinhardt RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature418,41–49 (2002).
  Medline CASGoogle Scholar
• 31  D’Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC: Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J. Cell Sci.117,2971–2981 (2004).
  MedlineGoogle Scholar
• 32  Kucia M, Reca R, Campbell FR et al.: A population of very small embryonic-like (VSEL) CXCR4⁺SSEA-1⁺Oct-4⁺ stem cells identified in adult bone marrow. Leukemia20,857–869 (2006).
  Medline CASGoogle Scholar
• 33  Zuba-Surma EK, Kucia M, Ratajczak J, Ratajczak MZ: “Small stem cells” in adult tissues: very small embryonic-like stem cells stand up! Cytometry A75,4–13 (2009).
  MedlineGoogle Scholar
• 34  McGuckin CP, Forraz N: Potential for access to embryonic-like cells from human umbilical cord blood. Cell Prolif.41(Suppl 1),31–40 (2008).
  MedlineGoogle Scholar
• 35  Siegel N, Rosner M, Hanneder M, Freilinger A, Hengstschlager M: Human amniotic fluid stem cells: a new perspective. Amino Acids35,291–293 (2008).
  Medline CASGoogle Scholar
• 36  Thomson JA, Itskovitz-Eldor J, Shapiro SS et al.: Embryonic stem cell lines derived from human blastocysts. Science282,1145–1147 (1998).▪▪ First description of embryonic stem cell (ESC) isolation from human blastocysts, 17 years after murine ESCs were isolated in 1981.
  Medline CASGoogle Scholar
• 37  Itskovitz-Eldor J, Schuldiner M, Karsenti D et al.: Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol. Med.6,88–95 (2000).
  Medline CASGoogle Scholar
• 38  Keller G: Embryonic stem cell differentiation: emergence of a new era in biology and medicine. Genes Dev.19,1129–1155 (2005).
  Medline CASGoogle Scholar
• 39  Rao BM, Zandstra PW: Culture development for human embryonic stem cell propagation: molecular aspects and challenges. Curr. Opin. Biotechnol.16,568–576 (2005).
  Medline CASGoogle Scholar
• 40  Kaufman DS, Hanson ET, Lewis RL, Auerbach R, Thomson JA: Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. USA98,10716–10721 (2001).▪▪ Excellent review of the use of pluripotent stem cells to generate all lineages of the hematopoietic system.
  Medline CASGoogle Scholar
• 41  Kaufman DS, Thomson JA: Human ES cells – hematopoiesis and transplantation strategies. J. Anat.200,243–248 (2002).
  Medline CASGoogle Scholar
• 42  Kaufman DS: Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells. Blood114,3513–3523 (2009).
  Medline CASGoogle Scholar
• 43  Daley GQ: From embryos to embryoid bodies: generating blood from embryonic stem cells. Ann. NY Acad. Sci.996,122–131 (2003).
  MedlineGoogle Scholar
• 44  Kennedy M, D’Souza SL, Lynch-Kattman M, Schwantz S, Keller G: Development of the hemangioblast defines the onset of hematopoiesis in human ES cell differentiation cultures. Blood109,2679–2687 (2007).
  Medline CASGoogle Scholar
• 45  Kyba M, Daley GQ: Hematopoiesis from embryonic stem cells: lessons from and for ontogeny. Exp. Hematol.31,994–1006 (2003).
  Medline CASGoogle Scholar
• 46  Snodgrass HR, Schmitt RM, Bruyns E: Embryonic stem cells and in vitrohematopoiesis. J. Cell Biochem.49,225–230 (1992).
  Medline CASGoogle Scholar
• 47  Wang L, Li L, Shojaei F, Levac K et al.: Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity21,31–41 (2004).
  Medline CASGoogle Scholar
• 48  Zambidis ET, Park TS, Yu W et al.: Expression of angiotensin-converting enzyme (CD143) identifies and regulates primitive hemangioblasts derived from human pluripotent stem cells. Blood112,3601–3614 (2008).
  Medline CASGoogle Scholar
• 49  Zambidis ET, Peault B, Park TS, Bunz F, Civin CI: Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac development. Blood106,860–870 (2005).▪▪ Excellent description of the multistep development of hematopoietic cells as they differentiate from human ESCs. Demonstrates that embryonic developmental processes are recapitulated in vitro.
  Medline CASGoogle Scholar
• 50  Okita K, Ichisaka T, Yamanaka S: Generation of germline-competent induced pluripotent stem cells. Nature448,313–317 (2007).
  Medline CASGoogle Scholar
• 51  Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell126,663–676 (2006).▪▪ Seminal discovery that somatic cells can be reprogrammed to become pluripotent by the transfection of four transcription factors.
  Medline CASGoogle Scholar
• 52  Wernig M, Meissner A, Foreman R et al.: In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature448,318–324 (2007).
  Medline CASGoogle Scholar
• 53  Takahashi K, Tanabe K, Ohnuki M et al.: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell131,861–872 (2007).▪▪ The demonstration that reprogramming with four transcription factors works in human cells.
  Medline CASGoogle Scholar
• 54  Yu J, Vodyanik MA, Smuga-Otto K et al.: Induced pluripotent stem cell lines derived from human somatic cells. Science318,1917–1920 (2007).▪▪ Demonstration that human somatic cells can be reprogrammed using two of the original reprogramming factors but replacing the other two, including c-MYC, with alternative transcription factors.
  Medline CASGoogle Scholar
• 55  Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K: Induced pluripotent stem cells generated without viral integration. Science322,945–949 (2008).
  Medline CASGoogle Scholar
• 56  Lacoste A, Berenshteyn F, Brivanlou AH: An efficient and reversible transposable system for gene delivery and lineage-specific differentiation in human embryonic stem cells. Cell Stem Cell5,332–342 (2009).
  Medline CASGoogle Scholar
• 57  Zhou H, Wu S, Joo JY et al.: Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell4,381–384 (2009).
  Medline CASGoogle Scholar
• 58  Ichida JK, Blanchard J, Lam K et al.: A small-molecule inhibitor of TGF-β signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell5,491–503 (2009).
  Medline CASGoogle Scholar
• 59  Lin T, Ambasudhan R, Yuan X et al.: A chemical platform for improved induction of human iPSCs. Nat. Methods6,805–808 (2009).
  Medline CASGoogle Scholar
• 60  Lengerke C, Daley GQ: Autologous blood cell therapies from pluripotent stem cells. Blood Rev.24(1),27–37 (2010).
  MedlineGoogle Scholar
• 61  Park IH, Arora N, Huo H et al.: Disease-specific induced pluripotent stem cells. Cell134,877–886 (2008).
  Medline CASGoogle Scholar
• 62  Feng Q, Lu SJ, Klimanskaya I et al.: Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells (2010) (Epub ahead of print).
  Google Scholar
• 63  Hu BY, Weick JP, Yu J et al.: Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA107(9),4335–4340 (2010).
  Medline CASGoogle Scholar
• 64  Olsen AL, Stachura DL, Weiss MJ: Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood107,1265–1275 (2006).
  Medline CASGoogle Scholar
• 65  Brendel C, Neubauer A: Characteristics and analysis of normal and leukemic stem cells: current concepts and future directions. Leukemia14,1711–1717 (2000).
  Medline CASGoogle Scholar
• 66  Lotem J, Sachs L: Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene21,3284–3294 (2002).
  Medline CASGoogle Scholar
• 67  Rosenbauer F, Koschmieder S, Steidl U, Tenen DG: Effect of transcription-factor concentrations on leukemic stem cells. Blood106,1519–1524 (2005).
  Medline CASGoogle Scholar
• 68  Tsiftsoglou AS, Vizirianakis IS, Strouboulis J: Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life61,800–830 (2009).▪▪ Very comprehensive but accessible description of erythropoiesis both in vitro and in vivo, and during embryo formation.
  Medline CASGoogle Scholar
• 69  Eilken HM, Nishikawa S, Schroeder T: Continuous single-cell imaging of blood generation from haemogenic endothelium. Nature457,896–900 (2009).
  Medline CASGoogle Scholar
• 70  Vodyanik MA, Bork JA, Thomson JA, Slukvin II: Human embryonic stem cell-derived CD34⁺ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential. Blood105,617–626 (2005).▪▪ First detailed description of multipotent hematopoietic cells generated in co-culture with stroma.
  Medline CASGoogle Scholar
• 71  Wege H, Le HT, Chui MS et al.: Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology124,432–444 (2003).
  Medline CASGoogle Scholar
• 72  Ng ES, Davis RP, Azzola L, Stanley EG, Elefanty AG: Forced aggregation of defined numbers of human embryonic stem cells into embryoid bodies fosters robust, reproducible hematopoietic differentiation. Blood106,1601–1603 (2005).
  Medline CASGoogle Scholar
• 73  Olivier EN, Qiu C, Velho M, Hirsch RE, Bouhassira EE: Large-scale production of embryonic red blood cells from human embryonic stem cells. Exp. Hematol.34,1635–1642 (2006).▪▪ First report of large-scale red blood cell production from human ESCs.
  Medline CASGoogle Scholar
• 74  Qiu C, Hanson E, Olivier E et al.: Differentiation of human embryonic stem cells into hematopoietic cells by coculture with human fetal liver cells recapitulates the globin switch that occurs early in development. Exp. Hematol.33,1450–1458 (2005).
  Medline CASGoogle Scholar
• 75  Qiu C, Olivier EN, Velho M, Bouhassira EE: Globin switches in yolk sac-like primitive and fetal-like definitive red blood cells produced from human embryonic stem cells. Blood111,2400–2408 (2008).
  Medline CASGoogle Scholar
• 76  Ma F, Ebihara Y, Umeda K et al.: Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis. Proc. Natl Acad. Sci. USA105,13087–13092 (2008).
  Medline CASGoogle Scholar
• 77  Lu SJ, Feng Q, Park JS et al.: Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood112,4475–4484 (2008).▪▪ Reported a high degree of expansion during red blood cell production from human ESCs and also demonstrated the functional characteristics of these cells were similar to those from cord blood. Used a process without co-culture that is amenable to scale-up to clinically useful numbers.
  Medline CASGoogle Scholar
• 78  Klump H, Schiedlmeier B, Baum C: Control of self-renewal and differentiation of hematopoietic stem cells: HOXB4 on the threshold. Ann. NY Acad. Sci.1044,6–15 (2005).
  Medline CASGoogle Scholar
• 79  Bowles KM, Vallier L, Smith JR, Alexander MR, Pedersen RA: HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells24,1359–1369 (2006).
  Medline CASGoogle Scholar
• 80  Kyba M, Perlingeiro RC, Daley GQ: HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell109,29–37 (2002).
  Medline CASGoogle Scholar
• 81  Lee GS, Kim BS, Sheih JH, Moore M: Forced expression of HoxB4 enhances hematopoietic differentiation by human embryonic stem cells. Mol. Cells25,487–493 (2008).
  Medline CASGoogle Scholar
• 82  Unger C, Karner E, Treschow A et al.: Lentiviral-mediated HoxB4 expression in human embryonic stem cells initiates early hematopoiesis in a dose-dependent manner but does not promote myeloid differentiation. Stem Cells26,2455–2466 (2008).
  Medline CASGoogle Scholar
• 83  Wang L, Menendez P, Shojaei F et al.: Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J. Exp. Med.201,1603–1614 (2005).
  Medline CASGoogle Scholar
• 84  Yao S, Chen S, Clark J et al.: Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl Acad. Sci. USA103,6907–6912 (2006).
  Medline CASGoogle Scholar
• 85  Chen S, Do JT, Zhang Q et al.: Self-renewal of embryonic stem cells by a small molecule. Proc. Natl Acad. Sci. USA103,17266–17271 (2006).
  Medline CASGoogle Scholar
• 86  Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH: Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med.10,55–63 (2004).
  Medline CASGoogle Scholar
• 87  Thomas RJ, Anderson D, Chandra A et al.: Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol. Bioeng.102,1636–1644 (2009).
  Medline CASGoogle Scholar
• 88  Oh SK, Chen AK, Mok Y et al.: Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res. 2009
  Google Scholar
• 89  Phillips BW, Horne R, Lay TS, Rust WL, Teck TT, Crook JM: Attachment and growth of human embryonic stem cells on microcarriers. J. Biotechnol.138,24–32 (2008).
  Medline CASGoogle Scholar
• 90  Li YJ, Chung EH, Rodriguez RT, Firpo MT, Healy KE: Hydrogels as artificial matrices for human embryonic stem cell self-renewal. J. Biomed. Mater. Res. A79,1–5 (2006).
  MedlineGoogle Scholar
• 91  Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G: Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc. Natl Acad. Sci. USA104,11298–11303 (2007).
  Medline CASGoogle Scholar
• 92  Siti-Ismail N, Bishop AE, Polak J M, Mantalaris A: The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials29,3946–3952 (2008).
  Medline CASGoogle Scholar
• 93  Krawetz R, Taiani JT, Liu S et al.: Large-scale expansion of pluripotent human embryonic stem cells in stirred suspension bioreactors. Tissue Eng. Part C Methods (2009) (Epub ahead of print).
  Google Scholar
• 94  Li X, Meng G, Krawetz R, Liu S, Rancourt DE: The ROCK inhibitor Y-27632 enhances the survival rate of human embryonic stem cells following cryopreservation. Stem Cells Dev.17,1079–1085 (2008).
  Medline CASGoogle Scholar
• 95  Ledran MH, Krassowska A, Armstrong L et al.: Efficient hematopoietic differentiation of human embryonic stem cells on stromal cells derived from hematopoietic niches. Cell Stem Cell3,85–98 (2008).
  Medline CASGoogle Scholar
• 96  Woll PS, Morris JK, Painschab MS et al.: Wnt signaling promotes hematoendothelial cell development from human embryonic stem cells. Blood111,122–131 (2008).
  Medline CASGoogle Scholar
• 97  Vijayaragavan K, Szabo E, Bosse M, Ramos-Mejia V, Moon RT, Bhatia M: Noncanonical Wnt signaling orchestrates early developmental events toward hematopoietic cell fate from human embryonic stem cells. Cell Stem Cell4,248–262 (2009).
  Medline CASGoogle Scholar
• 98  Wilson A, Trumpp A: Bone-marrow hematopoietic-stem-cell niches. Nat. Rev. Immunol.6,93–106 (2006).▪▪ Excellent review of what has been discovered so far regarding the complexity of the hematopoietic niche and its control over stem cells behavior.
  Medline CASGoogle Scholar
• 99  North TE, Goessling W, Walkley CR et al.: Prostaglandin E2 regulates vertebrate hematopoietic stem cell homeostasis. Nature447,1007–1011 (2007).
  Medline CASGoogle Scholar
• 100  North TE, Goessling W, Peeters M et al.: Hematopoietic stem cell development is dependent on blood flow. Cell137,736–748 (2009).
  Medline CASGoogle Scholar
• 101  Manca L, Masala B: Disorders of the synthesis of human fetal hemoglobin. IUBMB Life60,94–111 (2008).
  Medline CASGoogle Scholar
• 102  Olivieri NF, Weatherall DJ: The therapeutic reactivation of fetal hemoglobin. Hum. Mol. Genet.7,1655–1658 (1998).
  Medline CASGoogle Scholar
• 103  Bessis M, Mize C, Prenant M: Erythropoiesis: comparison of in vivo and in vitro amplification. Blood Cells4,155–174 (1978).
  Medline CASGoogle Scholar
• 104  Qiu LB, Dickson H, Hajibagheri N, Crocker PR: Extruded erythroblast nuclei are bound and phagocytosed by a novel macrophage receptor. Blood85,1630–1639 (1995).
  Medline CASGoogle Scholar
• 105  Zhang J, Ney PA: Autophagy-dependent and -independent mechanisms of mitochondrial clearance during reticulocyte maturation. Autophagy5,1064–1065 (2009).
  MedlineGoogle Scholar
• 106  Zhang J, Randall MS, Loyd MR et al.: Mitochondrial clearance is regulated by Atg7-dependent and -independent mechanisms during reticulocyte maturation. Blood114,157–164 (2009).
  Medline CASGoogle Scholar
• 107  Zhang J, Kundu M, Ney PA: Mitophagy in mammalian cells: the reticulocyte model. Methods Enzymol.452,227–245 (2009).
  Medline CASGoogle Scholar
• 108  Kundu M, Lindsten T, Yang CY et al.: Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood112,1493–1502 (2008).
  Medline CASGoogle Scholar
• 109  Liu J, Guo X, Mohandas N, Chasis JA, An X: Membrane remodeling during reticulocyte maturation. Blood115(10),2021–2027 (2009).
  MedlineGoogle Scholar
• 110  Migliaccio AR, Whitsett C, Migliaccio G: Erythroid cells in vitro: from developmental biology to blood transfusion products. Curr. Opin. Hematol.16,259–268 (2009).
  MedlineGoogle Scholar
• 111  James V: Guidelines for the Blood Transfusion Services in the United Kingdom. The Stationary Office, UK (2005).
  Google Scholar
• 112  Hiroyama T, Miharada K, Sudo K, Danjo I, Aoki N, Nakamura Y: Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One3,e1544 (2008).
  MedlineGoogle Scholar
• 113  Timmins NE, Nielsen LK: Blood cell manufacture: current methods and future challenges. Trends Biotechnol.27,415–422 (2009).
  Medline CASGoogle Scholar
• 201  Marking Rsearch Bureau www.marketingresearchbureau.com/home2.htm
  Google Scholar
• 202  Serious Hazards of Transfusion (SHOT) Annual Report 2008 www.shotuk.org/home/
  Google Scholar
• 203  Human Fertilization and Embryology Authority, UK www.hfea.gov.uk
  Google Scholar
• 204  Human Tissue Authority, UK www.hta.gov.uk
  Google Scholar
• 205  The European Medicines Agency www.ema.europa.eu
  Google Scholar
• 206  UK Stem Cell Tool Kit, Department of Health www.sc-toolkit.ac.uk/home.cfm
  Google Scholar
• 207  Experimental Medicine Tool Kit, the Medical Research Council www.em-toolkit.ac.uk/home.cfm
  Google Scholar